Pharmaceuticals, Biotechnology and Life Sciences
Don't spend too much on your repeated translations.
Cut costs with Vikler Media. Visit: media.vikler.net
Secarna to collaborate with Scenic to develop first-in-class disease-modifying oligonucleotide therapies for severe genetic diseases.
Bristol Myers Squibb and Bain Capital announced Monday the creation of a new independent biopharmaceutical company, called NewCo, which will be focused on developing new therapies for autoimmune diseases that...
Micrima, a Bristol-based health tech company, is urging women to give themselves the gift of prioritising knowledge of their breast density this Christmas. Dense breast tissue is a relatively unknown but common breast cancer risk factor, which additionally makes it...
Brenntag, the global market leader in chemicals and ingredients distribution, held a celebration to mark its 150-year anniversary yesterday in...
Over-65s across the UK are set to benefit from potentially life-changing new treatment options for conditions like cancer and cardiovascular...
SAN FRANCISCO–(BUSINESS WIRE)–#biotechshowcase–As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year, the event continued to distinguish itself as…
SAN FRANCISCO–(BUSINESS WIRE)–Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced…
$11.6M Department of Defense-supported pivotal study evaluates rapid, personalized, drug-free neuromodulation therapy for postpartum depression BURLINGAME, Calif.–(BUSINESS WIRE)–#PPD—Magnus Medical, Inc.,…
New retrospective analysis showed Orca-T with reduced intensity conditioning (RIC) demonstrated favorable OS, RFS and GRFS compared to PTCy Company…
Developed with IBSA’s innovative FilmTec® technology that dissolves in the mouth without the need for food or water Approved in…
New launches in high-content imaging, detection, and automation help labs accelerate drug discovery workflows from sample to insight WALTHAM, Mass.–(BUSINESS…
Experienced biotech executive brings more than 20 years of leadership experience in company creation, strategy, and drug development AMSTERDAM &…
Revenue of $4,364 million for the fourth quarter, $16,310 million for the full year GAAP Net Income of $514 million…
The Omnipod 5 Automated Insulin Delivery System is now commercially available in Saudi Arabia, Kuwait, Qatar, and the United Arab…
Latest investment marks key milestone in the company’s global growth strategy, supporting clients across an increasingly complex healthcare landscape LONDON–(BUSINESS…
